International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 20-23 , April 2010

Peripheral neuropathy in type-II diabetic patients attending diabetic clinics in Al-Azhar University Hospitals, Egypt

  • Khaled Kasim

      Affiliations

    • Department of Public Health and Community Medicine, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 2 24035279.
    • ,
  • Morsy Amar

      Affiliations

    • Department of Public Health and Community Medicine, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt
    • ,
  • Abdel Aziz El Sadek

      Affiliations

    • Department of Public Health and Community Medicine, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt
    • ,
  • Said Abdel Gawad

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Received 3 September 2009 ,Accepted 5 October 2009.

References 

  1. World Health Organization. Report on the second regional meeting on diabetes prevent-ion and control. Muscat-Oman, EMRO (WHO-EM/DIA/8/ E/L); 1997.
  2. Braunwald E, Fauci AS, Kasper DL. Harrison principles of internal medicine. 15th ed.. New York: McGraw-Hill; 2001;
  3. Dyck PJ, Thomas PK. Diabetic neuropathy. 2nd ed.. Philadelphia, WB: Saunders; 1999;
  4. Melton LJ, Service FJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–824
  5. Assem H, Mahmoud S, Omar M, Khalil I, AbdelMegeed MA, Saad S. Assessment of subclinical neuropathy in children with insulin dependent diabetes mellitus. Endocrine Abstracts. 2005;9:10
  6. Kahn RC, Weir CG. Diabetes mellitus. 13th ed.. Pennsylvania: Lea and Febiger Inc.; 1994;
  7. Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002;50:546–550
  8. Barbosa AP, Medina JL, Ramos EP, Barros HP. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab. 2001;27:496–502
  9. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol. 1999;12:553–563
  10. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–1289
  11. Lunetta M, Le Moli R, Grasso G, Sangiorgio L. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract. 1998;39:165–172
  12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC6). Arch Intern Med 1997;157:2413–44.
  13. World Health Organization multinational study of vascular diseases in diabetes. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers. Diabetologia 1985;28:615–7.
  14. Breslow NE, Day NE. Statistical methods in cancer research. Volume II, the design and analysis of case-control studies. Lyon: IARC; 1980;
  15. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors. The Euro Diab IDDM complications study. Diabetologia. 1996;39:1377–1384
  16. Manuel Malacara J, Eugenia Davalos L, Cervantes F, Castillo J, Velasco E. Risk factors of the complications of diabetes mellitus. Rev Invest Clin. 1991;43:3–9
  17. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley diabetes study. Am J Epidemiol. 1990;131:633–643
  18. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes. 1989;38:1456–1461
  19. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003;45:405–413
  20. Patel K, Schlundt D, Larson C, Wang H, Brown A, Hargreaves M. Chronic illness and smoking cessation. Nicotine Tobacco Res. 2009;11(8):933–939
  21. Çaliskan D, Ozdemir O, Ocaktan E, Idil A. Evaluation of awareness of diabetes mellitus and associated factors in four health center areas. Patient Educ Couns. 2006;62:142–147
  22. Sturm R, Gresenz CR. Relations of income inequality and family income to chronic medical conditions and mental health disorders: national survey. BMJ. 2002;324(7328):20
  23. Ikeda A, Iso H, Toyoshima H. Marital status and mortality among Japanese men and women: the Japan collaborative cohort study. BMC Public Health. 2007;7:73
  24. The DCCT Research Group . Factors in the development of diabetic neuropathy in feasibility phase of diabetes control and complications trial. Diabetes. 1988;37:476–481
  25. Nasr CE, Hoogwerf BJ, Faiman C, Reddy SS. United Kingdom prospective diabetes study (UKPDS). Effect of glucose and blood pressure control on complications of type 2 diabetes mellitus. Cleve Clin J Med. 1999;66:247–253

PII: S1877-5934(09)00054-X

doi: 10.1016/j.ijdm.2009.10.002

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 20-23 , April 2010

Article Tools